Year All20262025202420232022202120202019 June 30, 2022 atai Life Sciences Company Kures Therapeutics Appoints Dr. Chad Beyer as Chief Executive Officer June 17, 2022 Stephen Bardin to Join atai Life Sciences as CFO Designate June 16, 2022 atai Life Sciences to Participate in Upcoming June Healthcare Conferences May 16, 2022 atai Life Sciences Reports First Quarter 2022 Financial Results and Business Update May 5, 2022 CORRECTION - atai Life Sciences to Announce First Quarter 2022 Financial Results and Business Update April 19, 2022 atai Life Sciences to Participate in Upcoming April Investor Conference April 5, 2022 Beckley Psytech Announces Dosing of First Healthy Volunteers in Phase 1 Clinical Trial Assessing Safety and Pharmacokinetics of Second Innovative Formulation of 5-MeO-DMT March 30, 2022 atai Life Sciences Announces Fourth Quarter and Full Year 2021 Financial Results, Reports on R&D Progress and Highlights Strategic Focus Areas of its Innovative Mental Health Platform March 23, 2022 atai Life Sciences to Host Conference Call and Webcast to Discuss Results for the Fourth Quarter and Full Year 2021 and Corporate Update March 21, 2022 atai Life Sciences to Participate in Upcoming March Investor Conferences
June 30, 2022 atai Life Sciences Company Kures Therapeutics Appoints Dr. Chad Beyer as Chief Executive Officer
May 5, 2022 CORRECTION - atai Life Sciences to Announce First Quarter 2022 Financial Results and Business Update
April 5, 2022 Beckley Psytech Announces Dosing of First Healthy Volunteers in Phase 1 Clinical Trial Assessing Safety and Pharmacokinetics of Second Innovative Formulation of 5-MeO-DMT
March 30, 2022 atai Life Sciences Announces Fourth Quarter and Full Year 2021 Financial Results, Reports on R&D Progress and Highlights Strategic Focus Areas of its Innovative Mental Health Platform
March 23, 2022 atai Life Sciences to Host Conference Call and Webcast to Discuss Results for the Fourth Quarter and Full Year 2021 and Corporate Update
